Subscribe To
Pharmaxis discoveries to get a a$1.4 million boost to advance cancer and skin disease treatments
Pharmaxis Ltd's drug discoveries have been given a boost after the Australian government awarded two grants totalling A$1.4 million to respected scie...
January 6, 2022, 12:21 am
Pharmaxis discoveries to get a a$1.4 million boost to advance cancer and skin disease treatments
Pharmaxis Ltd's drug discoveries have been given a boost after the Australian government awarded two grants totalling A$1.4 million to respected scie...
January 6, 2022, 12:21 am
Pharmaxis discoveries to get a $1.4m boost to advance cancer and skin disease treatments
Pharmaxis Ltd's drug discoveries have been given a boost after the Australian government awarded two grants totalling $1.4 million to respected scien...
January 6, 2022, 12:15 am
Pharmaxis discoveries to get a $1.4m boost to advance cancer and skin disease treatments
Pharmaxis Ltd's drug discoveries have been given a boost after the Australian government awarded two grants totalling $1.4 million to respected scien...
January 6, 2022, 12:15 am
Pharmaxis discoveries to get a $1.4m boost to advance cancer and skin disease treatments
Pharmaxis Ltd's drug discoveries have been given a boost after the Australian government awarded two grants totalling $1.4 million to respected scien...
January 6, 2022, 12:15 am
4 oil & gas stocks that more than doubled in 2021
With several vaccines and treatments in hand to combat coronavirus, fuel demand has improved dramatical...
December 31, 2021, 1:00 pm
4 oil & gas stocks that more than doubled in 2021
With several vaccines and treatments in hand to combat coronavirus, fuel demand has improved dramatical...
December 31, 2021, 1:00 pm
4 oil & gas stocks that more than doubled in 2021
With several vaccines and treatments in hand to combat coronavirus, fuel demand has improved dramatical...
December 31, 2021, 1:00 pm
Merck's (mrk) covid pill gets fda nod for emergency use
Merck's (MRK) oral antiviral molnupiravir secures the FDA-authorized emergency use tag in treating mild-to-moderate COVID-19 in adults for whom other ...
December 24, 2021, 1:48 pm
Merck's (mrk) covid pill gets fda nod for emergency use
Merck's (MRK) oral antiviral molnupiravir secures the FDA-authorized emergency use tag in treating mild-to-moderate COVID-19 in adults for whom other ...
December 24, 2021, 1:48 pm
Merck's (mrk) covid pill gets fda nod for emergency use
Merck's (MRK) oral antiviral molnupiravir secures the FDA-authorized emergency use tag in treating mild-to-moderate COVID-19 in adults for whom other ...
December 24, 2021, 1:48 pm
Imugene secures fda approval for two clinical trials of promising oncology drug candidates
Imugene Limited (ASX:IMU, OTC:IUGNF) has obtained US Food and Drug Administration (FDA) consent for clinical trials for two of its oncology ...
December 12, 2021, 7:40 pm
Imugene secures fda approval for two clinical trials of promising oncology drug candidates
Imugene Limited (ASX:IMU, OTC:IUGNF) has obtained US Food and Drug Administration (FDA) consent for clinical trials for two of its oncology ...
December 12, 2021, 7:40 pm
Imugene secures fda approval for two clinical trials of promising oncology drug candidates
Imugene Limited (ASX:IMU, OTC:IUGNF) has obtained US Food and Drug Administration (FDA) consent for clinical trials for two of its oncology ...
December 12, 2021, 7:40 pm
Akero therapeutics to present at the evercore isi 4th annual healthconx virtual conference
SOUTH SAN FRANCISCO, Nov. 26, 2021 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational...
November 26, 2021, 5:28 pm
Akero therapeutics to present at the evercore isi 4th annual healthconx virtual conference
SOUTH SAN FRANCISCO, Nov. 26, 2021 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational...
November 26, 2021, 5:28 pm
Akero therapeutics to present at the evercore isi 4th annual healthconx virtual conference
SOUTH SAN FRANCISCO, Nov. 26, 2021 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational...
November 26, 2021, 5:28 pm
Journey medical aims for $35 million ipo
Journey Medical Corporation has filed proposed terms for a $35.2 million IPO. The firm develops and sells trea...
November 11, 2021, 1:17 pm
Journey medical aims for $35 million ipo
Journey Medical Corporation has filed proposed terms for a $35.2 million IPO. The firm develops and sells trea...
November 11, 2021, 1:17 pm
Journey medical aims for $35 million ipo
Journey Medical Corporation has filed proposed terms for a $35.2 million IPO. The firm develops and sells trea...
November 11, 2021, 1:17 pm